Increased expression of urotensin II and its cognate receptor GPR14 in atherosclerotic lesions of the human aorta
about
The role of urotensin II in cardiovascular and renal physiology and diseasesRole of PKC in the novel synergistic action of urotensin II and angiotensin II and in urotensin II-induced vasoconstrictionThe G Protein-Coupled Receptor UT of the Neuropeptide Urotensin II Displays Structural and Functional Chemokine Features.Protein expression of urotensin II, urotensin-related peptide and their receptor in the lungs of patients with lymphangioleiomyomatosisHemodynamic effects of chronic urotensin II administration in animals with and without aorto-caval fistulaPotential Clinical Implications of the Urotensin II Receptor Antagonists.Urotensin II contributes to the formation of lung adenocarcinoma inflammatory microenvironment through the NF-κB pathway in tumor-bearing nude mice.A closer look at the role of urotensin II in the metabolic syndrome.Urotensin-II Immunoreactivity in Normolipidemic and Hyperlipidemic New Zealand White Rabbits Following Balloon Angioplasty and Stenting.The Urotensin II System and Carotid Atherosclerosis: A Role in Vascular CalcificationReceptors, endocytosis, and trafficking: the biological basis of targeted delivery of antisense and siRNA oligonucleotidesInhibitory Effect of an Urotensin II Receptor Antagonist on Proinflammatory Activation Induced by Urotensin II in Human Vascular Endothelial Cells.Urotensin II in cardiovascular regulation.Plasma urotensin II and neurokinin B levels in acute myocardial infarction and stable coronary artery disease.Role of urotensin II in health and disease.Novel pathways and therapies in experimental diabetic atherosclerosis.Palosuran inhibits binding to primate UT receptors in cell membranes but demonstrates differential activity in intact cells and vascular tissues.Nonpeptidic urotensin-II receptor antagonists I: in vitro pharmacological characterization of SB-706375.Urotensin-II: More Than a Mediator for Kidney.The relationship of urotensin II with insulin resistance and hs-CRP in patients having PCOS.The relationship between coronary slow flow phenomenon and urotensin-II: A prospective and controlled study.Urotensin II receptor antagonism confers vasoprotective effects in diabetes associated atherosclerosis: studies in humans and in a mouse model of diabetes.Indole-2-carboxamide Derivatives as Potent Urotensin-II Receptor (UT) Antagonists1,3,4-Thiadiazol-2-amine Derivatives as Urotensin-II Receptor (UT) Antagonists
P2860
Q24675590-4FF89F2D-12A9-4184-AAC1-442D6D5D0F17Q28572971-809F9820-8B51-4E96-B517-FD0436869389Q33599835-7DF94D08-3E35-4E2E-8E2B-11A99A525CEBQ34001118-4963DE40-6CF4-4B91-BF48-9C6FBDE2A083Q34248766-C1B1F2CB-1EEB-4CFC-AD0A-1841B2C72DB1Q35128456-7D91B23A-CED1-4550-A1EE-0211C79BA45AQ36424203-AA360FF7-CB6C-4A41-8CE1-C082B808CFBFQ36492706-CDA57005-6CD8-45EB-B36F-D628A682CEB6Q36735227-FBABD3B6-EE59-4F7C-9CCF-898F21F73C59Q36973674-5EAB7166-D099-449A-AC31-703A9CE8661EQ37015817-7D7F7173-A40A-456F-B56F-82AD6092C3A3Q37286280-E7C89EAA-696A-4DB7-9DB6-6B4375531E25Q37344439-846BBDEF-7B45-4232-AE60-51A16E0494CAQ37680436-16FFF781-D7EE-480E-981A-343C28EBEA4BQ37737495-1DD2DFE3-8B7C-4742-8453-D887AF627909Q37990618-13AD7B53-3D45-4E39-A066-036BB70858AAQ39967100-0E315B2C-B6D1-4D92-8A52-3CE914374602Q40430686-3493D6EF-8592-44A8-9EC3-C3ACA127DF06Q42418210-2C21C1E9-C2A6-4207-A209-67682C1E042FQ46084798-276A29E6-DF48-487F-B92C-4B86C6A92151Q49526717-DF0A3F65-ED1B-4C10-8BF7-DD1CF7323D9CQ50796108-BA702299-2F9D-4769-B3BC-ECD0F46F46FAQ57771749-1B530D5C-81D8-45A5-98C0-8B693EE6F825Q57771763-E1C3BEDD-18A6-4F95-930F-9A3B2D9C9911
P2860
Increased expression of urotensin II and its cognate receptor GPR14 in atherosclerotic lesions of the human aorta
description
2004 nî lūn-bûn
@nan
2004 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Increased expression of uroten ...... tic lesions of the human aorta
@ast
Increased expression of uroten ...... tic lesions of the human aorta
@en
Increased expression of uroten ...... tic lesions of the human aorta
@nl
type
label
Increased expression of uroten ...... tic lesions of the human aorta
@ast
Increased expression of uroten ...... tic lesions of the human aorta
@en
Increased expression of uroten ...... tic lesions of the human aorta
@nl
prefLabel
Increased expression of uroten ...... tic lesions of the human aorta
@ast
Increased expression of uroten ...... tic lesions of the human aorta
@en
Increased expression of uroten ...... tic lesions of the human aorta
@nl
P2093
P3181
P1433
P1476
Increased expression of uroten ...... tic lesions of the human aorta
@en
P2093
Adel Giaid
Eliot H Ohlstein
Lisa Patel
Nicolas Bousette
Stephen A Douglas
P304
P3181
P356
10.1016/J.ATHEROSCLEROSIS.2004.03.023
P407
P577
2004-09-01T00:00:00Z